feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / AI Medical Device Malfunctions Spark Safety Concerns

AI Medical Device Malfunctions Spark Safety Concerns

9 Feb

•

Summary

  • AI integrated into surgical device linked to over 100 malfunctions.
  • Patients allegedly injured, including strokes and fluid leaks.
  • FDA faces challenges keeping pace with AI medical device approvals.
AI Medical Device Malfunctions Spark Safety Concerns

AI integration into medical devices has raised significant safety concerns. Since late 2021, Johnson & Johnson's TruDi Navigation System for chronic sinusitis surgery, which incorporates AI, has been associated with over 100 reported malfunctions and adverse events. Reports indicate at least 10 patient injuries, including strokes and cerebrospinal fluid leaks, with lawsuits alleging the AI misled surgeons.

The U.S. Food and Drug Administration (FDA) is grappling with the rapid increase in AI-enhanced medical devices, with over 1,357 now authorized. A review found many AI devices have higher recall rates compared to similar non-AI products. The agency faces staffing challenges in its ability to adequately assess the safety and efficacy of these rapidly evolving technologies.

Integra LifeSciences, which acquired the TruDi system, denies a causal link between the AI and alleged injuries. Meanwhile, other AI-assisted devices, including a heart monitor and an ultrasound device, have also faced scrutiny for malfunctions. The FDA acknowledges the growing promise of AI in healthcare but is working to enhance its capacity for regulatory oversight.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Since late 2021, the TruDi Navigation System has been linked to over 100 malfunctions and adverse events, with reports of at least 10 patient injuries, including strokes and fluid leaks.
The FDA is struggling to keep pace with the increasing number of AI-enhanced medical devices, facing staffing challenges in assessing their safety and efficacy.
Integra LifeSciences, which acquired the TruDi system, denies any causal link between the AI technology and alleged patient injuries.

Read more news on

Healthside-arrowArtificial Intelligence (AI)side-arrow
trending

PFC REC merger approved

trending

Tata Steel share price surges

trending

ITC stock market stability

trending

SBI share price jumps

trending

ITA Airways promotes Olympics

trending

Brandon McMullen scores 41

trending

Scotland seek Italy revenge

trending

Zimbabwe vs Oman T20

trending

Kruthik Krishna proves mettle

You may also like

AI Fuels Biotech Leap: New Cures on Horizon

6 Feb • 17 reads

article image

AI Spots Silent Killer: Cancer Caught Early

3 Feb • 39 reads

article image

AI Speeds Drug Trials, But True Cures Await

26 Jan • 85 reads

AI Detects Fetal Abnormalities: FDA Clears Biotics AI

19 Jan • 137 reads

article image

Pharma Races to AI: A New Era of Drug Discovery

15 Jan • 142 reads

article image